|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
|
CALCIMEDICA, INC. (Name of Issuer) |
Common Stock, par value $0.0001 per share (Title of Class of Securities) |
(CUSIP Number) |
Valence Investments SPV IV LLC 590 Madison Avenue, 21st Floor, New York, NY, 10022 (212) 521-4379 Valence Investment SPV VI LLC Dorsey & Whitney LLP, 430 Cowper Street, Suite 250 Palo Alto, NY, 94301 (650) 565-2252 Valence Investment SPV VI LLC 590 Madison Avenue, 21st Floor, New York, NY, 10022 (212) 521-4379 Eric Roberts 590 Madison Avenue, 21st Floor, New York, NY, 10022 (212) 521-4379 Rachel Leheny 590 Madison Avenue, 21st Floor, New York, NY, 10022 (212) 521-4379 Evan Ng Dorsey & Whitney LLP, 430 Cowper Street, Suite 250 Palo Alto, CA, 94301 (650) 565-2252 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
06/25/2026 (Date of Event Which Requires Filing of This Statement) |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Valence Investments SPV IV, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
356,989.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
1.2 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Valence Investments SPV V, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
86,098.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.3 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Valence Investments SPV VI, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
316,109.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
1.0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Eric W. Roberts | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
1,965,916.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
6.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
A. Rachel Leheny | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
1,926,347.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
6.3 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN, IA |
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common Stock, par value $0.0001 per share | |
| (b) | Name of Issuer:
CALCIMEDICA, INC. | |
| (c) | Address of Issuer's Principal Executive Offices:
505 Coast Boulevard South, Suite 307, La Jolla,
CALIFORNIA
, 92037. | |
Item 1 Comment:
Reference is hereby made to the statements on Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on March 30, 2023, as amended by Amendment No 1 filed with the SEC on November 22, 2023, Amendment No 2 filed with the SEC on February 8, 2024 and Amendment No 3 filed with the SEC on November 6, 2024 (collectively, the "Schedule 13D"), which is incorporated by reference.
This Amendment No 4 to the Schedule 13D filed, relating to the common stock, par value $0.0001 per share (the "Common Stock") of CalciMedica, Inc., a Delaware corporation (the "Issuer") amends and supplements certain of the items set forth therein. | ||
| Item 3. | Source and Amount of Funds or Other Consideration | |
Item 3 is hereby amended supplemented by adding the following at the end of Item 3:
Open-Market Purchases
Since November 6, 2024, Mr. Roberts and Ms. Leheny have made purchases of Common Stock in open market transactions using their personal funds. Such transactions are described in greater detail in Item 5 below.
Securities Purchase Agreement
On June 23,2026, the Issuer entered into a Securities Purchase Agreement underwriting agreement with existing institutional and accredited investors relating to the issuance and sale in a public offering of 18,673,429 Units, each Unit comprised of one share of the Issuer's Common Stock, and one pre-funded warrant to purchase one share of Common Stock. The price in the offering was $0.8033 per Unit. Mr. Roberts and Ms. Leheny purchased 186,729 Units. The offering closed on June 25, 2026. Mr. Roberts and Ms. Leheny each used personal funds to acquire the Units. | ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | Item 5 is hereby amended and supplemented as follows:
The Reporting Persons effected the following transactions in the Common Stock on the dates indicated, and such transactions are the only transactions in the Common Stock by the Reporting Persons in the sixty days preceding the filing of this Amendment, or since the last 13D filing, whichever is less:
Name Nature of Transaction Date Number of Shares of Common Stock Price per Share
Roberts Open Market Purchase 6/5/2025 5,100 $1.6638 to 1.7274
Roberts Open Market Purchase 6/6/2025 5,000 $1.75 to 1.87
Roberts Open Market Purchase 6/11/2025 5,000 $1.85
Roberts Open Market Purchase 6/26/2025 4,500 $1.43 to $1.4499
Roberts Open Market Purchase 7/09/2025 5,000 $1.6047
Leheny Open Market Purchase 7/14/2025 2,500 $2.47
Roberts Open Market Purchase 7/14/2025 6,500 $2.30 to $2.55
Roberts Open Market Purchase 7/18/2025 2,000 $2.88
Leheny Open Market Purchase 7/21/2025 1,000 $3.40
Roberts Open Market Purchase 7/21/2025 1,500 $3.37
Roberts Open Market Purchase 7/22/2025 1,500 $3.775
Roberts Open Market Purchase 8/15/2025 5,076 $2.8977
Roberts Option Exercise 8/20/2025 15,000 $1.53
Roberts Open Market Purchase 8/19/2025 1,000 $2.79
Roberts Open Market Purchase 8/20/2025 2,000 $2.72
Roberts Open Market Purchase 8/21/2025 3,508 $2.75 to 2.80
Roberts Open Market Purchase 8/28/2025 9,200 $2.75 to $2.92
Roberts Open Market Purchase 8/29/2025 800 $2.74
Roberts Open Market Purchase 9/9/2025 2,343 $2.75 to $3.21
Roberts Open Market Purchase 9/12/2025 5,000 $3.12
Roberts Open Market Purchase 9/15/2025 3,400 $2.65 to $2.70
Roberts Open Market Purchase 9/18/2025 2,500 $3.07
Leheny Purchase in Private Placement 6/25/2026 186,729 $0.8033
Roberts Purchase in Private Placement 6/25/2026 186,729 $0.8033 | |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
|
|